Medicines Development for Global Health

Medicines Development for Global Health develops medicines and vaccines for neglected diseases. Our approach is to combine the ideas of researchers with our development expertise and passion to create new products that will change the lives of millions. We are a non-profit company, and all funds beyond expenses are dedicated to this purpose. In June 2018, we received FDA approval for moxidectin, the first new treatment for river blindness in over 20 years. Next, we turned our attention to the potential benefits of moxidectin for other neglected tropical diseases and scabies. Biotechnology drug development provides development expertise for small and medium-sized biopharmaceutical industries. We specialize in providing in-house clinical research teams to bring immediate industry expertise, standard operating procedures, and associated project management.